Uddin Mohammad M, Tanimoto Takeshi, Yabuki Akira, Kotani Takao, Kuwamura Mitsuru, Chang Hye-Sook, Yamato Osamu
Laboratory of Clinical Pathology, Joint Faculty of Veterinary Medicine, Kagoshima University, Japan.
J Feline Med Surg. 2012 Dec;14(12):900-2. doi: 10.1177/1098612X12454120. Epub 2012 Jul 6.
GM1 gangliosidosis is a fatal, progressive neurodegenerative lysosomal storage disease caused by mutations of the β-galactosidase (GLB1) gene. In feline GM1 gangliosidosis, a pathogenic mutation (c.1448G>C) of the feline GLB1 gene was identified in Siamese and Korat cats previously diagnosed with the disease in the USA and Italy, respectively. The present study demonstrated the same mutation in a Siamese cat that had been diagnosed with GM1 gangliosidosis in Japan in the 1960s. The mutation was confirmed using DNA extracted from stored paraffin-embedded brain tissue by a direct sequencing method and a polymerase chain reaction-restriction fragment length polymorphism assay. This pathogenic mutation seems to have been distributed around the world.
GM1神经节苷脂贮积症是一种由β-半乳糖苷酶(GLB1)基因突变引起的致命性、进行性神经退行性溶酶体贮积病。在猫GM1神经节苷脂贮积症中,先前在美国和意大利分别被诊断患有该疾病的暹罗猫和呵叻猫中鉴定出猫GLB1基因的致病突变(c.1448G>C)。本研究在一只于20世纪60年代在日本被诊断患有GM1神经节苷脂贮积症的暹罗猫中证实了相同的突变。通过直接测序法和聚合酶链反应-限制性片段长度多态性分析,使用从储存的石蜡包埋脑组织中提取的DNA证实了该突变。这种致病突变似乎已在世界各地传播。